Because of the complexity of the factors that influence the effect of metformin on adiponectin levels, we could not identify through our meta-analysis the precise dose or duration of metformin therapy needed to maximize the increase in adiponectin concentration in patients with PCOS. The gene discussed is ADIPOQ; the disease is polycystic ovary syndrome.